Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Gestrinone

🥰Excellent
Catalog No. T7223Cas No. 16320-04-0
Alias R 2323

Gestrinone (R 2323) is a synthetic androgen receptor agonist and ER and progesterone receptor antagonist used to treat endometriosis. It inhibits leiomyoma cells with an IC50 of 43.67 μM.

Gestrinone

Gestrinone

🥰Excellent
Purity: 99.21%
Catalog No. T7223Alias R 2323Cas No. 16320-04-0
Gestrinone (R 2323) is a synthetic androgen receptor agonist and ER and progesterone receptor antagonist used to treat endometriosis. It inhibits leiomyoma cells with an IC50 of 43.67 μM.
Pack SizePriceAvailabilityQuantity
5 mg$31In Stock
10 mg$48In Stock
25 mg$87In Stock
50 mg$129In Stock
100 mg$188In Stock
200 mg$283In Stock
1 mL x 10 mM (in DMSO)$36In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:99.21%
Contact us for more batch information
Resource Download
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.

Product Introduction

Bioactivity
Description
Gestrinone (R 2323) is a synthetic androgen receptor agonist and ER and progesterone receptor antagonist used to treat endometriosis. It inhibits leiomyoma cells with an IC50 of 43.67 μM.
Targets&IC50
Leiomyoma cells:43.67 μM (IC50)
In vivo
Mifepristone combined with gestrinone had satisfactory clinical therapeutic effects on endometriosis by reducing hormone levels and improving pregnancy outcomes[1].
Animal Research
A total of 150 endometriotic patients were randomly divided into a control group and a treatment group (n=75). The control group began to orally take gestrinone capsules on the second day after menstruation started (2.5 mg/time, twice/week). The treatment group orally took mifepristone tablets (12.5 mg/time, once/day), and the dosage and administration of gestrinone capsules were the same as those of the control group. After 24 weeks of consecutive treatment, the clinical therapeutic effects of the two groups were assessed, and the pelvic symptom score, clinical sign score, serum sex hormone levels and pregnancy outcomes were compared[1].
AliasR 2323
Chemical Properties
Molecular Weight308.41
FormulaC21H24O2
Cas No.16320-04-0
Smiles[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Relative Density.1.18g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (162.12 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2424 mL16.2122 mL32.4244 mL162.1219 mL
5 mM0.6485 mL3.2424 mL6.4849 mL32.4244 mL
10 mM0.3242 mL1.6212 mL3.2424 mL16.2122 mL
20 mM0.1621 mL0.8106 mL1.6212 mL8.1061 mL
50 mM0.0648 mL0.3242 mL0.6485 mL3.2424 mL
100 mM0.0324 mL0.1621 mL0.3242 mL1.6212 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Gestrinone | purchase Gestrinone | Gestrinone cost | order Gestrinone | Gestrinone chemical structure | Gestrinone in vivo | Gestrinone formula | Gestrinone molecular weight